person · Reporting owner

Fitterling James R

Disclosed activity across 5 companies

Tapewire entity: 47849
SEC CIK: 0001490029

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
3M COMMM · Entity 1275	Director	May 12, 2026	May 13, 2026
DOW INC.DOW · Entity 3233	Director · Chair and CEO	February 12, 2026	May 01, 2026
TCF FINANCIAL CORPCHFC · Entity 106138	Director	June 21, 2019	June 24, 2019

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

3M CO

Report date May 12, 2026 · Filed May 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Corporation	7,868.463	Reported balance After 2026-05-12 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-05-12 · Grant · Acquired 1,360.402 · Balance 7,868.463 F1: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors. F2: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.
Common StockSEC Table I · non-derivative	Direct	11,412.005	Reported balance Holding disclosure · report date 2026-05-12 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 11,412.005
Common StockSEC Table I · non-derivative	IndirectBy Spouse	200	Reported balance Holding disclosure · report date 2026-05-12 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 200

Filing footnotes · ownership attribution and instrument terms

F1: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

F2: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.

DOW INC.

Report date February 12, 2026 · Filed May 01, 2026 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	190,117	Reported balance After 2026-02-12 transaction · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · 2026-02-12 · Grant · Acquired 68,230 · Balance 190,117 F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment. F2: Total includes previously reported restricted stock units. F3: This amount represents the correct amount of securities beneficially owned by the Reporting Person following the reported transaction. The Form 4 filed by the Reporting Person on February 17, 2026 erroneously reported a transaction that did not occur. This amendment is being filed solely to remove the erroneously reported transaction in its entirety and corrects the total amount reflected in this column.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment.

F2: Total includes previously reported restricted stock units.

F3: This amount represents the correct amount of securities beneficially owned by the Reporting Person following the reported transaction. The Form 4 filed by the Reporting Person on February 17, 2026 erroneously reported a transaction that did not occur. This amendment is being filed solely to remove the erroneously reported transaction in its entirety and corrects the total amount reflected in this column.

TCF FINANCIAL CORP

Report date June 21, 2019 · Filed June 24, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock UnitsSEC Table II · derivative / convertible security	Direct	11,201.86	Reported balance After 2019-06-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2019-06-21 · Grant · Acquired 4,710.089 · Balance 11,201.86 F1: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.
Stock UnitsSEC Table II · derivative / convertible security	Direct	11,298.403	Reported balance After 2019-06-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-06-21 · Grant · Acquired 96.543 · Balance 11,298.403 F2: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.

Filing footnotes · ownership attribution and instrument terms

F1: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.

F2: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

DOW CHEMICAL CO /DE/

Report date August 31, 2017 · Filed September 05, 2017

Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
CommonSEC Table I · non-derivative	Direct	Reported balance After 2017-08-31 transaction · row 1 1 source row Row 1 · 2017-08-31 · Disposition to issuer · Disposed 258,154.949 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 25,810 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 19,410 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan	Reported balance After 2017-08-31 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-08-31 · Disposition to issuer · Disposed 1,634.041 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
CommonSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	Reported balance After 2017-08-31 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-08-31 · Disposition to issuer · Disposed 4,384.6034 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10	Direct	Reported balance After 2017-08-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-08-31 · Disposition to issuer · Disposed 61,830 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10	Direct	Reported balance After 2017-08-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-08-31 · Disposition to issuer · Disposed 98,690 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2021-02-11	Direct	Reported balance After 2017-08-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-08-31 · Disposition to issuer · Disposed 118,090 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12	Direct	Reported balance After 2017-08-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-08-31 · Disposition to issuer · Disposed 130,140 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13	Direct	Reported balance After 2017-08-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-08-31 · Disposition to issuer · Disposed 95,610 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14	Direct	Reported balance After 2017-08-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-08-31 · Disposition to issuer · Disposed 96,220 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15	Direct	Reported balance After 2017-08-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-08-31 · Disposition to issuer · Disposed 210,880 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option was fully vested and exercisable at the time of the Merger.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.

F2: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 25,810 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 19,410 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.

F3: This option was fully vested and exercisable at the time of the Merger.

F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.

F5: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.

F6: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.

F7: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.

DuPont de Nemours, Inc.

Report date April 01, 2019 · Filed April 04, 2019

Section 16 reporting ended · disclosed 2019-04-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	140,193	Reported balance After 2019-04-01 transaction · row 1 1 source row Row 1 · 2019-04-01 · Grant · Acquired 55,650 · Balance 140,193 F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment.
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan	1,909.623	Reported balance Holding disclosure · report date 2019-04-01 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 1,909.623
Common StockSEC Table I · non-derivative	IndirectBy 401(k) Plan ESOP	5,166.068	Reported balance Holding disclosure · report date 2019-04-01 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 5,166.068
Common StockSEC Table I · non-derivative	IndirectBy Trust	217,287.949	Reported balance Holding disclosure · report date 2019-04-01 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 217,287.949

Filing footnotes · ownership attribution and instrument terms

F1: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 01, 2019 Filed Apr 4, 2019 01:51 UTC	DOW INC. DOW · Entity 3233	GrantCommon Stock	20,939	$0.00	$0.00	Disclosure SEC source: 0000899243-19-009938 · doc4.xml · nonDerivative · entry 2 Fitterling James R · CIK 0001490029 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,119 F3 · shares: Performance share units not previously reportable vested upon the timely completion of the separation of the Issuer from DowDuPont Inc. on April 1, 2019. The performance share units were adjusted pursuant to the terms of the Employee Matters Agreement. Performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment and further adjustment pursuant to the Employee Matters Agreement. F2 · balance_after: On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019. Total includes one share of common stock of the Issuer received for every three shares of DowDuPont common stock in connection with the separation. Read SEC document
April 01, 2019 Filed Apr 4, 2019 01:51 UTC	DOW INC. DOW · Entity 3233	GrantCommon Stock	66,425	$0.00	$0.00	Disclosure SEC source: 0000899243-19-009938 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,180 F1 · shares: In connection with the separation, certain outstanding DowDuPont restricted stock units were converted into restricted stock units of the Issuer pursuant to the terms of the Employee Matters Agreement. The number of shares was adjusted in a manner intended to preserve the economic/intrinsic value of the original DowDuPont restricted share unit award. Restricted stock units to be delivered in one installment on or about the following dates, subject to continued employment: 66,425 shares on or about February 10, 2020. F2 · balance_after: On April 1, 2019, the Issuer separated from DowDuPont Inc. by issuing a dividend of the Issuer's common stock as further described in the Information Statement filed as Exhibit 99.1 to Form 10 filed by the Issuer on March 8, 2019. Total includes one share of common stock of the Issuer received for every three shares of DowDuPont common stock in connection with the separation. Read SEC document
April 01, 2019 Filed Apr 4, 2019 01:42 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	GrantCommon Stock	55,650	$0.00	$0.00	Disclosure SEC source: 0001225208-19-006407 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,193 F1 · shares: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment. F1 · price: Performance share units not previously reportable vested upon determination by the DowDuPont Inc. Compensation Committee on April 1, 2019, that the synergy capture maximum performance criteria had been met. Additional performance-based targets remain. Performance share units will be settled in one installment on or about September 1, 2019, subject to continued employment. Read SEC document
March 15, 2019 Filed Mar 18, 2019 16:22 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	49.892	$43.90	$2,190.26	Disclosure SEC source: 0000019612-19-000072 · wf-form4_155294055006057.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,491.771 Underlying: Common Stock · 49.892 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
February 26, 2019 Filed Feb 28, 2019 23:22 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Disposition to issuerCommon Stock	55,752	$55.88	$3,115,421.76	Disclosure SEC source: 0001225208-19-004007 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,543 F1 · kind: The deferred shares of Common stock converted from performance based awards to be delivered on or about February 12, 2019, were settled in cash on February 26, 2019 at the election of the Reporting Person. Read SEC document
February 12, 2019 Filed Feb 15, 2019 00:08 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	8,545	$53.36	$455,961.20	Disclosure SEC source: 0001225208-19-002604 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,295 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Shares used to satisfy withholding taxes on delivery of deferred stock granted February 12, 2016 as previously reported. Read SEC document
December 21, 2018 Filed Dec 26, 2018 08:21 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	60.504	$35.86	$2,169.67	Disclosure SEC source: 0000019612-18-000162 · wf-form4_154583046681031.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,441.879 Underlying: Common Stock · 60.504 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
December 04, 2018 Filed Dec 6, 2018 22:02 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	GiftCommon Stock	4,215	$0.00	$0.00	Disclosure SEC source: 0001225208-18-016295 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 217,287.949 Read SEC document
September 21, 2018 Filed Sep 25, 2018 08:27 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	38.098	$56.61	$2,156.73	Disclosure SEC source: 0000019612-18-000138 · wf-form4_153787841829488.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,381.375 Underlying: Common Stock · 38.098 shares Expires not disclosed F1 · security: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
August 14, 2018 Filed Aug 14, 2018 18:47 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative	10,500	$0.00 Strike: $32.16	$0.00	Disclosure SEC source: 0001225208-18-012529 · doc4.xml · derivative · entry 5 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,210 Underlying: Common Stock · 10,500 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F2 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document
August 14, 2018 Filed Aug 14, 2018 18:47 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionCommon Stock	10,500	$32.16	$337,680.00	Disclosure SEC source: 0001225208-18-012529 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 15, 2018 Filed Jun 18, 2018 15:38 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	30.423	$58.10	$1,767.58	Disclosure SEC source: 0000019612-18-000096 · wf-form4_152935070334884.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,343.277 Underlying: Common Stock · 30.423 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
May 31, 2018 Filed Jun 4, 2018 12:39 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	3,266.443	$56.12	$183,312.78	Disclosure SEC source: 0000019612-18-000081 · wf-form4_152813031044686.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,268.306 Underlying: Common Stock · 3,266.443 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
May 31, 2018 Filed Jun 15, 2018 15:59 UTC Amendment	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	3,310.991	$56.12	$185,812.81	Disclosure SEC source: 0000019612-18-000092 · wf-form4a_152909272944196.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,312.854 Underlying: Common Stock · 3,310.991 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F2 · shares: The amounts in columns 5, 7 and 9 have been amended, as they were incorrect as originally reported by the reporting person. F1 · derivative.exercise_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F2 · derivative.underlying_shares: The amounts in columns 5, 7 and 9 have been amended, as they were incorrect as originally reported by the reporting person. F2 · balance_after: The amounts in columns 5, 7 and 9 have been amended, as they were incorrect as originally reported by the reporting person. Read SEC document
May 18, 2018 Filed May 22, 2018 20:32 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	GiftCommon Stock	8,877	$0.00	$0.00	Disclosure SEC source: 0001225208-18-009734 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,842.949 Read SEC document
March 16, 2018 Filed Mar 19, 2018 16:31 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	14.358	$58.26	$836.50	Disclosure SEC source: 0000019612-18-000056 · wf-form4_152149149428260.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,001.863 Underlying: Common Stock · 14.358 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
February 20, 2018 Filed Feb 22, 2018 22:18 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Disposition to issuerCommon Stock	50,183	$71.62	$3,594,106.46	Disclosure SEC source: 0001225208-18-003810 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,719.949 F1 · kind: The deferred shares of Common stock converted from performance based awards to be delivered on or about February 13, 2018, were settled in cash on February 20, 2018 at the election of the Reporting Person. Read SEC document
February 15, 2018 Filed Feb 21, 2018 00:41 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	GrantNon-Qualified Stock Option (Right to Buy) · Derivative	307,245	$0.00 Strike: $71.85	$0.00	Disclosure SEC source: 0001225208-18-003480 · doc4.xml · derivative · entry 4 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,245 Underlying: Common Stock · 307,245 shares Expires 2028-02-15 F3 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: This option will vest in three equal installments beginning on February 15, 2019. Option shares may be used to satisfy withholding taxes. Read SEC document
February 13, 2018 Filed Feb 21, 2018 00:41 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	6,102	$70.75	$431,716.50	Disclosure SEC source: 0001225208-18-003480 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,902.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Shares used to satisfy withholding taxes on delivery of deferred stock granted February 13, 2015 as previously reported. Read SEC document
December 19, 2017 Filed Dec 21, 2017 10:56 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	60.799	$54.82	$3,333.00	Disclosure SEC source: 0000019612-17-000112 · wf-form4_151387179228077.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,987.505 Underlying: Common Stock · 60.799 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing committee retainers voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing committee retainers voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing committee retainers voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
December 15, 2017 Filed Dec 19, 2017 15:08 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	14.725	$55.37	$815.32	Disclosure SEC source: 0000019612-17-000104 · wf-form4_151371409143201.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,926.706 Underlying: Common Stock · 14.725 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
November 29, 2017 Filed Dec 1, 2017 13:44 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	GiftCommon Stock	10,842	$0.00	$0.00	Disclosure SEC source: 0001225208-17-017922 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,004.949 Read SEC document
November 28, 2017 Filed Nov 30, 2017 16:27 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GiftCommon Stock	4,630	$0.00	$0.00	Disclosure SEC source: 0000905729-17-000315 · fitterling4_113017.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,414.358 Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative	22,170	$0.00 Strike: $32.16	$0.00	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · derivative · entry 10 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,710 Underlying: Common Stock · 22,170 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative	61,830	$0.00 Strike: $34.00	$0.00	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · derivative · entry 9 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,830 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	29,566	$71.11	$2,102,290.43	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 6 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,846.949 Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	14,907	$71.11	$1,059,962.24	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 5 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,412.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	10,028	$71.11	$713,040.94	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 4 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,319.949 Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Tax withholdingCommon Stock	5,610	$71.11	$398,899.05	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 3 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,347.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionCommon Stock	22,170	$32.16	$712,987.20	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 2 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,957.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 09, 2017 Filed Nov 13, 2017 21:15 UTC	DuPont de Nemours, Inc. DWDP · Entity 3297	Exercise / conversionCommon Stock	61,830	$34.00	$2,102,220.00	Disclosure SEC source: 0001225208-17-017211 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,787.949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 15, 2017 Filed Sep 19, 2017 14:19 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	98.965	$48.61	$4,810.69	Disclosure SEC source: 0000905729-17-000264 · fitterling4_091917.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,911.981 Underlying: Common Stock · 98.965 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	210,880	Not disclosed Strike: $32.16	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 10 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 210,880 shares Expires 2023-02-15 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	96,220	Not disclosed Strike: $46.71	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 9 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 96,220 shares Expires 2024-02-14 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	95,610	Not disclosed Strike: $49.44	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 8 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 95,610 shares Expires 2025-02-13 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F7 · derivative.exercise_date: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	130,140	Not disclosed Strike: $46.01	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 7 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 130,140 shares Expires 2026-02-12 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6 · derivative.exercise_date: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	118,090	Not disclosed Strike: $38.38	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 6 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 118,090 shares Expires 2021-02-11 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	98,690	Not disclosed Strike: $61.19	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 5 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 98,690 shares Expires 2027-02-10 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5 · derivative.exercise_date: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative	61,830	Not disclosed Strike: $34.00	Not disclosed	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · derivative · entry 4 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 61,830 shares Expires 2022-02-10 F4 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerCommon	4,384.6034	$0.00	$0.00	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · nonDerivative · entry 3 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan ESOP Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerCommon	1,634.041	$0.00	$0.00	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · nonDerivative · entry 2 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document
August 31, 2017 Filed Sep 5, 2017 21:08 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Disposition to issuerCommon	258,154.949	$0.00	$0.00	Disclosure SEC source: 0001225208-17-014591 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2 · shares: Includes 18,710 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 25,810 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 19,410 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document
June 16, 2017 Filed Jun 20, 2017 10:45 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	138.856	$48.65	$6,755.34	Disclosure SEC source: 0000905729-17-000220 · fitterling4_062017.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813.016 Underlying: Common Stock · 138.856 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
May 05, 2017 Filed May 9, 2017 09:30 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	2,590.41	$49.22	$127,499.98	Disclosure SEC source: 0000905729-17-000189 · fitterling4_050917.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,674.16 Underlying: Common Stock · 2,590.41 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
March 17, 2017 Filed Mar 21, 2017 09:48 UTC	TCF FINANCIAL CORP CHFC · Entity 106138	GrantStock Units · Derivative	83.75	$54.00	$4,522.50	Disclosure SEC source: 0000905729-17-000134 · fitterling4_032117.xml · derivative · entry 1 Fitterling James R · CIK 0001490029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83.75 Underlying: Common Stock · 83.75 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing board and committee fees and dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document
February 14, 2017 Filed Feb 16, 2017 21:16 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Tax withholdingCommon	6,809	$61.72	$420,251.48	Disclosure SEC source: 0001225208-17-003571 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,950.949 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Stock withheld on the delivery date to cover taxes for deferred stock granted on February 14, 2014, as previously reported. Read SEC document
February 10, 2017 Filed Feb 14, 2017 21:14 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	GrantNon-Qualified Stock Option (right to buy) · Derivative	98,690	$0.00 Strike: $61.19	$0.00	Disclosure SEC source: 0001225208-17-003205 · doc4.xml · derivative · entry 4 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,690 Underlying: Common · 98,690 shares Expires 2027-02-10 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 10, 2018. Read SEC document
February 10, 2017 Filed Feb 14, 2017 21:14 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	GrantCommon	19,410	$0.00	$0.00	Disclosure SEC source: 0001225208-17-003205 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,759.949 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F2 · shares: Deferred shares to be delivered in one installment on or about February 10, 2020 contingent upon continuation of employment. Read SEC document
February 08, 2017 Filed Feb 10, 2017 21:52 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	7,700	$0.00 Strike: $27.79	$0.00	Disclosure SEC source: 0001225208-17-002785 · doc4.xml · derivative · entry 10 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 7,700 shares Expires 2020-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2011. Read SEC document
February 08, 2017 Filed Feb 10, 2017 21:52 UTC	DOW CHEMICAL CO /DE/ DOW · Entity 97744	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	85,300	$0.00 Strike: $34.00	$0.00	Disclosure SEC source: 0001225208-17-002785 · doc4.xml · derivative · entry 9 Fitterling James R · CIK 0001490029 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,830 Underlying: Common · 85,300 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 10, 2013. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.